Measurement of serum estrogen and estrogen metabolites in pre- and postmenopausal women with osteoarthritis using high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 2, 2015, Pages 146-153

  Gao, Wan Li ^a   Wu, L S ^a   Zi, J H ^a   Wu, B ^a   Li, Y Z ^b   Song, Y C ^c   Cai, D Z ^c  

^a LINYI PEOPLE'S HOSPITAL   (China)

^b Guangdong Institute for Drug Control   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen; Estrogen metabolites; Menopause; Osteoathritis; Serum

Indexed keywords

16ALPHA HYDROXYESTRONE; 2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; ESTRIOL; ESTROGEN; ESTRONE; ESTRONE DERIVATIVE; 16-HYDROXYESTRONE; 2-HYDROXYESTRADIOL; 2-HYDROXYESTRONE; ESTRADIOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ESTROGEN METABOLISM; ESTROGEN URINE LEVEL; FEMALE; FOLLICULAR PHASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF DETECTION; LUTEAL PHASE; MEASUREMENT PRECISION; OSTEOARTHRITIS; POSTMENOPAUSE; PRODUCT RECOVERY; SOLVENT EXTRACTION; ANALOGS AND DERIVATIVES; BLOOD; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PREMENOPAUSE; PROCEDURES;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; ESTRIOL; ESTROGENS; ESTRONE; FEMALE; FOLLICULAR PHASE; HUMANS; HYDROXYESTRONES; LIMIT OF DETECTION; LUTEAL PHASE; MIDDLE AGED; OSTEOARTHRITIS; POSTMENOPAUSE; PREMENOPAUSE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STATISTICS, NONPARAMETRIC;

EID: 84922226973     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144129     Document Type: Article

References (38)

1. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000; 21: 427-433, doi: 10.1093/carcin/21.3.427.
2. Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, et al. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006; 1766: 63-78.
3. Lim SK, Won YJ, Lee JH, Kwon SH, Lee EJ, Kim KR, et al. Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 1997; 82: 1001-1006, doi: 10.1210/jcem.82.4.3875.
4. Hodge J, Roodman-Weiss J, Lyss C, Wagner D, Klug T, Civitelli R. Increased inactive estrogen metabolites in urine of early postmenopausal women with low bone density. J Bone Miner Res 1995; 10: S444.
5. Sowers MR, McConnell D, Jannausch M, Buyuktur AG, Hochberg M, Jamadar DA. Estradiol and its metabolites and their association with knee osteoarthritis. Arthritis Rheum 2006; 54: 2481-2487, doi: 10.1002/art.22005.
6. Fishman J. Aromatic hydroxylation of estrogens. Annu Rev Physiol 1983; 45: 61-72, doi: 10.1146/annurev.ph.45.030183.000425.
7. Lotinun S, Westerlind KC, Turner RT. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alphahydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats. J Endocrinol 2001; 170: 165-174, doi: 10.1677/joe.0.1700165.
8. Robinson JA, Waters KM, Turner RT, Spelsberg TC. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells. J Bone Miner Res 2000; 15: 499-506, doi: 10.1359/jbmr.2000.15.3.499.
9. MacLusky NJ, Riskalla M, Krey L, Parvizi N, Naftolin F. Anovulation in female rats induced by neonatal administration of the catechol estrogens, 2-hydroxy-estradiol and 4- hydroxy-estradiol. Neuroendocrinology 1983; 37: 321-327, doi: 10.1159/000123569.
10. Tang M, Abplanalp W, Ayres S, Subbiah MT. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism 1996; 45: 411-414, doi: 10.1016/S0026-0495(96)90212-7.
11. Szabo A. [A technic for the determination of ethinyl estradiol and norgestrel]. Acta Pharm Hung 1977; 47: 24-28.
12. Stan HJ, Hohls FW. [Detection of estrogen residues in meat by thin layer chromatography and fluorimetry (author’s transl)]. Z Lebensm Unters Forsch 1978; 166: 287-292, doi: 10.1007/BF01127655.
13. Numazawa M, Kimura K, Nagaoka M, Kambegawa A. Radioimmunoassay of 2-hydroxyesterone using antisera raised against antigenic complexes obtained by convenient methods. Chem Pharm Bull 1989; 37: 1561-1563, doi: 10.1248/cpb.37.1561.
14. McGuinness BJ, Power MJ, Fottrell PF. Radioimmunoassay of 2-hydroxyestrone in urine. Clin Chem 1994; 40: 80-85.
15. Bradlow HL, Sepkovic DW, Klug T, Osborne MP. Application of an improved ELISA assay to the analysis of urinary estrogen metabolites. Steroids 1998; 63: 406-413, doi: 10.1016/S0039-128X(98)00041-5.
16. Adlercreutz H, Tikkanen MJ, Hunneman DH. Mass fragmentographic determination of eleven estrogens in the body fluids of pregnant and nonpregnant subjects. J Steroid Biochem 1974; 5: 211-217, doi: 10.1016/0022-4731(74)90134-4.
17. Higashi T, Takayama N, Nishio T, Taniguchi E, Shimada K. Procedure for increasing the detection responses of estrogens in LC-MS based on introduction of a nitrobenzene moiety followed by electron capture atmospheric pressure chemical ionization. Anal Bioanal Chem 2006; 386: 658-665, doi: 10.1007/s00216-006-0371-z.
18. Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG. Quantitativemeasurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography- tandem mass spectrometry. Anal Chem 2007; 79: 7813-7821, doi: 10.1021/ac070494j.
19. Rothman MS, Carlson NE, Xu M, Wang C, Swerdloff R, Lee P, et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography- tandem mass spectrometry. Steroids 2011; 76: 177-182, doi: 10.1016/j.steroids.2010.10.010.
20. Carvalho VM. The coming of age of liquid chromatography coupled to tandem mass spectrometry in the endocrinology laboratory. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 883-884: 50-58, doi: 10.1016/j.jchromb.2011.08.027.
21. Hu JB, Gu HC, Ding ZS, Yao L, Fan YS, Ding XH. [Study on intervention effect of Jieduquyuziyin prescription systemic lupus erythematosus by HPLC-Q-TOF/MS]. Zhongguo Zhong Yao Za Zhi 2013; 38: 3747-3752.
22. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-1049, doi: 10.1002/art.1780290816.
23. Lachance L, Sowers MF, Jamadar D, Hochberg M. The natural history of emergent osteoarthritis of the knee in women. Osteoarthritis Cartilage 2002; 10: 849-854, doi: 10.1053/joca.2002.0840.
24. Cecil RL, Archer BH. Arthritis of the menopause. J Am Med Assoc 1925; 84: 75-79, doi: 10.1001/jama.1925.02660280001001.
25. Wluka AE, Cicuttini FM, Spector TD. Menopause, oestrogens and arthritis. Maturitas 2000; 35: 183-199, doi: 10.1016/S0378-5122(00)00118-3.
26. Ushiyama T, Ueyama H, Inoue K, Ohkubo I, Hukuda S. Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage 1999; 7: 560-566, doi: 10.1053/joca.1999.0260.
27. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 2006; 91: 3791-3797, doi: 10.1210/jc.2005-2378.
28. Stanczyk FZ, Jurow J, Hsing AW. Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2010; 19: 903-906, doi: 10.1158/1055-9965.EPI-10-0081.
29. Yang DT, Owen WE, Ramsay CS, Xie H, Roberts WL. Performance characteristics of eight estradiol immunoassays. Am J Clin Pathol 2004; 122: 332-337, doi: 10.1309/5N2R4HT4GM0AGPBY.
30. Jaque J, Macdonald H, Brueggmann D, Patel SK, Azen C, Clarke N, et al. Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients. Springerplus 2013; 2: 5, doi: 10.1186/2193-1801-2-5.
31. Rosner W, Hankinson SE, Sluss PM, Vesper HW, Wierman ME. Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab 2013; 98: 1376-1387, doi: 10.1210/jc.2012-3780.
32. Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol 2010; 121: 491-495, doi: 10.1016/j.jsbmb.2010.05.001.
33. Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH. Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 2010; 121: 496-504, doi: 10.1016/j.jsbmb.2010.04.010.
34. Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem 2011; 44: 77-88, doi: 10.1016/j.clinbiochem.2010.07.008.
35. Santen RJ, Demers L, Ohorodnik S, Settlage J, Langecker P, Blanchett D, et al. Superiority of gas chromatography/ tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids 2007; 72: 666-671, doi: 10.1016/j.steroids.2007.05.003.
36. Rocha MJ, Cruzeiro C, Rocha E. Development and validation of a GC-MS method for the evaluation of 17 endocrine disruptor compounds, including phytoestrogens and sitosterol, in coastal waters - their spatial and seasonal levels in Porto costal region (Portugal). J Water Health 2013; 11: 281-296, doi: 10.2166/wh.2013.021.
37. Twaddle NC, Churchwell MI, Newbold RR, Delclos KB, Doerge DR. Determination using liquid-chromatographyelectrospray tandem mass spectroscopy of ethinylestradiol serum pharmacokinetics in adult Sprague-Dawley rats. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 793: 309-315, doi: 10.1016/S1570-0232(03)00331-3.
38. Aizawa Y. [Double isotope method - with special reference to estrogen (sulfonylating reagent 35S method)]. Nihon Rinsho 1971; 29: 1267-1272.